Nearly 200 Medical School faculty members earned promotions in the 2024 cycle. Their new appointments were approved May 16 by the U-M Board of regents and take effect Sept. 1, 2024.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.

Telehealth study of patient portal e-visits by Medicare participants shows few had an interaction for which their provider billed them.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Former DCMB PhD student Dr. Shuze Wang was published in Developmental Cell.

Congratulations to incoming intern, Chioma Anidi on being the 2024 recipient of the Albert C. Furstenberg Award

Meet the newest residents to join our program

New website to help adolescents with disabilities learn about reproductive health.

2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

Cases of kidney stones in children are increasing, but parents can minimize the chances their kids develop them.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.